The assessment of neuropathic pain in patients with prediabetes

Basit Öğe Kaydı
dc.authoridcakal, erman/0000-0003-4455-7276
dc.authoridHEPSEN, SEMA/0000-0002-8375-7409
dc.contributor.authorHepsen, Sema
dc.contributor.authorKeskin, Dilek Baday
dc.contributor.authorCakal, Erman
dc.date.accessioned2025-01-21T16:44:53Z
dc.date.available2025-01-21T16:44:53Z
dc.date.issued2023
dc.departmentKırıkkale Üniversitesi
dc.description.abstractAims: Neuropathic pain is associated with several clinical conditions, including anxiety, depression, sleep dis-orders, and decreased quality of life; however, less evaluated in prediabetes. This study aims to assess neuro-pathic pain through validated diagnostic tools in prediabetes.Methods: One hundred and seventy-two patients with prediabetes and 170 controls were included in this cross-sectional study. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale and Douleur Neuropathique 4 Questions (DN4) were used to evaluate neuropathic pain. The Visual Analog Scale (VAS) was used to estimate pain intensity.Results: Twenty-three (13.4%) and 12 (7%) patients with prediabetes were diagnosed with neuropathic pain using DN4 and LANSS questionnaires, respectively. Neuropathic pain rates of the patients were higher than controls with two pain scales (p < 0.001). VAS scores were higher in prediabetes group than in controls (p = 0.021). LANSS, DN4, and VAS scores were positively correlated with HbA1c level (r = 0.184, p = 0.016; r = 0.180, p = 0.018; r = 0.188, p = 0.014, respectively). LANNS and DN4 scores were higher in female patients than in males (p < 0.001).Conclusions: Neuropathic pain was increased in prediabetes by DN4 and LANNS questionnaires. An appropriate diagnosis of neuropathic pain in prediabetes may prevent patients from different pain-related clinical conditions.
dc.identifier.doi10.1016/j.pcd.2022.11.004
dc.identifier.endpage37
dc.identifier.issn1751-9918
dc.identifier.issn1878-0210
dc.identifier.issue1
dc.identifier.pmid36435735
dc.identifier.scopus2-s2.0-85142527901
dc.identifier.scopusqualityQ2
dc.identifier.startpage33
dc.identifier.urihttps://doi.org/10.1016/j.pcd.2022.11.004
dc.identifier.urihttps://hdl.handle.net/20.500.12587/25541
dc.identifier.volume17
dc.identifier.wosWOS:000963646000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.ispartofPrimary Care Diabetes
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.subjectDN4; LANNS; Neuropathic pain; Prediabetes; VAS
dc.titleThe assessment of neuropathic pain in patients with prediabetes
dc.typeArticle

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu